NCT00689208View on ClinicalTrials.gov

Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions

Insulin Resistance

Interventions

DRUG

Atropine

10 ug/kg bolus, 4 ug/kg/h infusion

DRUG

Physostigmine

0,12ug/kg/min

DRUG

Placebo Sodium

Trial Locations (1)

Unknown

Research Site, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY